Skip to content

Oraverse Versus Laser

Comparative Study of the Effect of Diode Laser and Oraverse on Reversing the Effect of Articaine 4% Soft Tissue Anasthesia in Children

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05473858
Acronym
RCT
Enrollment
36
Registered
2022-07-26
Start date
2021-12-10
Completion date
2026-04-10
Last updated
2026-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Reversal of Local Anesthesia in Children

Brief summary

clinically assess the reversal of articaine 4% of two different concentration of vasoconcentration soft-tissue local anesthesia in pediatric dentistry using Diode Laser and Oraverse

Detailed description

Patients will be divided randomly into two groups (20 patients in each group) Group (1): Patients will be undergoing anesthesia revision by diode laser Group (2): Patients will be undergoing anesthesia revision by oraverse. Then each group will be subdivided into 2 subgroups (10 patients each) according to type of local anesthetic agent into: subgroup 1: Articaine 4% with 1:100000 epinephrin &Subgroup 2: Articaine 4% with 1:200000 epinephrin After 30 min of injection corresponding to approximate time of treatment, the patient in each group will be exposed to the reversal agent which may be diode laser or oraverse.

Interventions

DRUGOraVerse Injectable Product

injection of oraverse,

DEVICEdiode laser

patient exposed to diode laser

OTHERAnaesthesia only

Patient exposed to anaesthesia without any more intervention

Sponsors

sara nabil
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
6 Years to 10 Years
Healthy volunteers
Yes

Inclusion criteria

1. Patients who need to be treated under anesthesia by injecting mandibular first molar infiltration. 2. Cooperative children aged 6 to 10 years old with the ability to understand and respond to the sensation of soft tissue -

Design outcomes

Primary

MeasureTime frameDescription
reversal of local anasthesia30 minutepatient free of lip numbness

Countries

Egypt

Contacts

CONTACTsara nabil, DR
snhasem@gmail.com00201006420998

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 7, 2026